title: Pre-procedural plasma levels of C-reactive protein and interleukin-6 do not predict late coronary angiographic restenosis after elective stenting.
abstract: OBJECTIVE
  Inflammatory markers may serve as an important prognostic predictor in patients with coronary heart diseases. In patients undergoing coronary interventions, it has been shown that baseline C-reactive protein (CRP) could predict late clinical restenosis. Only a few small studies have examined the possible relationship with angiographic restenosis. In patients with stable angina pectoris,we examined whether baseline CRP and IL-6 predict late coronary angiographic restenosis after stenting.
  
  
  RESULTS
  Pre-procedural plasma levels of CRP and IL-6 were measured in 216 patients with stable angina pectoris undergoing elective coronary stenting. Angiographic follow-up was performed in all patients at 6 months. Baseline CRP levels were 6.15 +/- 0.78 mg/L versus 5.24 +/- 1.17 mg/L in the patent and restenosis groups, respectively (P=0.64). IL-6 levels were 0.46 +/- 0.03 ng/L versus 0.40 +/- 0.07 ng/L in the patent and restenosis groups, respectively (P=0.50). CRP levels were obtained again at the time of angiographic follow-up and were found to be similar in both groups (2.89 +/- 0.29 mg/L versus 2.61 +/- 0.63 mg/L, P=0.72). Moreover, in a sub-group of 43 patients, serial blood samples were obtained at several time points after the procedure up to 6 months. Both CRP and IL-6 plasma levels increased significantly in response to the procedure. CRP levels peaked at 3 days (11.27 +/- 1.53 mg/L versus 4.26 +/- 0.72 mg/L at baseline, P<0.0001). IL-6 levels reached maximum values after 24 h (1.08 +/- 0.14 ng/L versus 0.53 +/- 0.08 ng/L at baseline, P<0.0001). However, in this sub-group of patients, neither peak CRP nor IL-6 levels were found to predict late angiographic restenosis.
  
  
  CONCLUSIONS
  Coronary stenting is associated with transient increases in both CRP and IL-6 levels. However, pre-procedural CRP and IL-6 levels do not predict late coronary angiographic restenosis.
authors.affiliation: The Roy and Ann Foss Cardiovascular Research Program, Terrence Donnelly Heart Center, Division of Cardiology, St. Michael's Hospital, 7CC-008, 30 Bond Street, University of Toronto, Toronto, Ont., Canada.
authors.forename: Amit
authors.initials: A
authors.lastname: Segev
authors.forename: Saleem
authors.initials: S
authors.lastname: Kassam
authors.forename: Christopher E
authors.initials: CE
authors.lastname: Buller
authors.forename: Herbert K
authors.initials: HK
authors.lastname: Lau
authors.forename: John D
authors.initials: JD
authors.lastname: Sparkes
authors.forename: Philip W
authors.initials: PW
authors.lastname: Connelly
authors.forename: Peter H
authors.initials: PH
authors.lastname: Seidelin
authors.forename: Madhu K
authors.initials: MK
authors.lastname: Natarajan
authors.forename: Eric A
authors.initials: EA
authors.lastname: Cohen
authors.forename: Bradley H
authors.initials: BH
authors.lastname: Strauss
mesh_terms: D000787:Angina Pectoris / Q000097:blood / Q000209:etiology / Q000601:surgery; D002097:C-Reactive Protein / Q000032:analysis*; D015331:Cohort Studies; D023903:Coronary Restenosis / Q000097:blood / Q000209:etiology* / Q000601:surgery; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015850:Interleukin-6 / Q000097:blood*; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D011300:Preoperative Care; D016032:Randomized Controlled Trials as Topic; D015607:Stents
chemical_list: D015850:Interleukin-6; D002097:C-Reactive Protein